
In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Kris Kaneta, chief product officer at Norstella, which is helping life sciences companies speed up development with instant strategy recommendations. Kaneta discusses AI in drug trials and commercialisation and just what’s possible when clinical AI has access to a data set robust enough to allow it to make real strategic recommendations. Kaneta also touches upon why patient-level data is pharma's most important asset in the AI race and the roadblocks that stand in the way of further expanding the efficacy of AI for clinical trials. You can listen to episode 261 to go here of the pharmaphorum podcast in the player below, download the episode to your computer, or find it – and subscribe to the rest of the series – on Apple Podcasts, Spotify, Overcast, Pocket Casts, Podbean, and pretty much wherever else you download your other podcasts from.
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.

Towards a healthier world: Momentum in UK health system transformation, with Lee-Ann Farrell

The cardio-renal-metabolic space and obesity as a chronic disease, with Ramy Younes

On the power of T-cells, with Cedrik Britten

Why everyone should care about longevity, with Boyang Wang
Free AI-powered recaps of pharmaphorum Podcast and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.